retatrutide lilly Eli stock jumps on Phase 3 weight loss results eli lilly trials retatrutide Lilly's

Semaglutides ability to help maintain appetite suppression over the long term without significant side effects makes it an ideal option for individuals seeking lasting weight loss results

Recipe created on: 7/7/2026

Gastrointestinal Adverse Events Of the adverse effects reported during GLP-1 RA clinical trials, gastrointestinal symptoms were the most frequent, with nausea and diarrhea very common, and vomiting, constipation, abdominal pain, and dyspepsia considered to be relatively common [97]

It's also totally curbed my appetite

By reducing stomach volume, ESG helps patients feel full sooner and eat smaller portions

We will use this information as part of your personalized program plan